LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 71.54 | 771.67 | 10649 | 10532 | 1.0110 | 1.0058 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 71.54 | 771.67 | 12522 | 10532 | 1.1888 | 1.0939 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 71.54 | 771.67 | 8788 | 10532 | 0.8343 | 0.9062 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 71.54 | 771.67 | 10256 | 10532 | 0.9737 | 0.9859 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 73.76 | 771.67 | 10920 | 10851 | 1.0063 | 1.0033 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 73.76 | 771.67 | 12860 | 10851 | 1.1851 | 1.0911 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 73.76 | 771.67 | 8919 | 10851 | 0.8219 | 0.8997 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 73.76 | 771.67 | 10568 | 10851 | 0.9739 | 0.9862 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.02 | 771.67 | 11290 | 11106 | 1.0165 | 1.0085 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.02 | 771.67 | 13245 | 11106 | 1.1925 | 1.0937 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.02 | 771.67 | 9059 | 11106 | 0.8156 | 0.8968 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.02 | 771.67 | 10936 | 11106 | 0.9846 | 0.9920 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.25 | 771.67 | 11590 | 11367 | 1.0196 | 1.0100 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.25 | 771.67 | 13608 | 11367 | 1.1971 | 1.0949 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.25 | 771.67 | 9132 | 11367 | 0.8033 | 0.8903 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.25 | 771.67 | 11177 | 11367 | 0.9832 | 0.9913 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 80.48 | 771.67 | 12003 | 11685 | 1.0272 | 1.0137 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 80.48 | 771.67 | 14011 | 11685 | 1.1991 | 1.0948 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 80.48 | 771.67 | 9289 | 11685 | 0.7950 | 0.8863 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 80.48 | 771.67 | 11452 | 11685 | 0.9801 | 0.9898 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.69 | 771.67 | 12290 | 11974 | 1.0264 | 1.0132 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.69 | 771.67 | 14324 | 11974 | 1.1963 | 1.0927 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.69 | 771.67 | 9257 | 11974 | 0.7731 | 0.8740 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 82.69 | 771.67 | 11836 | 11974 | 0.9885 | 0.9942 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 84.92 | 771.67 | 12597 | 12266 | 1.0269 | 1.0134 | MN20160304_L01 | G22 |